Prescription Stimulant Prescribing, Nonmedical Use, and Shortages

This Viewpoint discusses developing better evidence about appropriate use of stimulants, understanding and reducing nonmedical use of these medications, and responding to shortages.

Authors

Institutions

Publication Details

Journal
JAMA Psychiatry
Published
2025-03-26
DOI
https://doi.org/10.1001/jamapsychiatry.2025.0099
Citations
2
Primary Topic
Attention Deficit Hyperactivity Disorder
Type
article
Field-Weighted Citation Impact
2.94
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prescription Stimulant Prescribing, Nonmedical Use, and Shortages

Joshua P. Rising, Robert M. Califf
2 citations
JAMA Psychiatry
Attention Deficit Hyperactivity Disorder
2.94
article

Prescription Stimulant Prescribing, Nonmedical Use, and Shortages

Joshua P. Rising, Robert M. Califf
article en
2 citations

Abstract

This Viewpoint discusses developing better evidence about appropriate use of stimulants, understanding and reducing nonmedical use of these medications, and responding to shortages.

JAMA PsychiatryVol. 82(5)
United States Food and Drug Administration (US), Duke University (US), Health Strat (Kenya) (KE)
Openalex Percentile: Top 11%
Attention Deficit Hyperactivity Disorder
2.94
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Prescription Stimulant Prescribing, Nonmedical Use, and Shortages — Joshua P. Rising, Robert M. Califf · JAMA Psychiatry (2025) | TGRS Research Map | TGRS